---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-020966"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2023-07-28T23:59:59+00:00"
generated_at: "2026-06-12T23:01:22.120879+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics files prospectus to sell up to $5.0M shares in at-the-market offering

## Summary
- Filed prospectus supplement under existing ATM agreement with H.C. Wainwright & Co. for up to $5.0M of common stock.
- Shares issued under effective S-3 registration statement (No. 333-272607) declared effective June 20, 2023.
- Proceeds not specified; general corporate purposes likely.

## SEC filing metadata
- accession: 0001437749-23-020966
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2023-07-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000143774923020966/0001437749-23-020966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000143774923020966/ekso20230726_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-020966
- JSON: https://secwatch.observer/filing/0001437749-23-020966.json
- Plain text: https://secwatch.observer/filing/0001437749-23-020966.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.